IgCP Exam Pharmacokinetics
2026 Exam Questions and
Correct Answers | New Update
What is pharmacokinetics? - 🧠 ANSWER ✔✔Study of a drug's absorption,
distribution, metabolism, and elimination (ADME)
What are the general pharmacokinetics of Ig products? - 🧠 ANSWER
✔✔IVIG administration - blood levels of Igs rise to a peak and then
decrease over time until the next infusion
, An Ig blood level taken just before a subsequent infusion is called the
trough level.
SCIG administration - the peaks and troughs are less dramatic, and there is
a more consistent, steady level over time
How is HyQvia administered? - 🧠 ANSWER ✔✔The HY component is
administered first at 1-2 mL per minute/infusion site or as tolerated.
Immediately following, within approximately 10 minutes, the Ig component
is infused through the same high flow subcutaneous needle set
What are other names for HyQvia? - 🧠 ANSWER ✔✔IgHy
fSCIG
What is the advantage of Hyaluronidase in HyQvia? - 🧠 ANSWER ✔✔it
transiently increases the permeability of
the subcutaneous tissue, allowing up to 600 mL of the Ig to be
administered per infusion site
2026 Exam Questions and
Correct Answers | New Update
What is pharmacokinetics? - 🧠 ANSWER ✔✔Study of a drug's absorption,
distribution, metabolism, and elimination (ADME)
What are the general pharmacokinetics of Ig products? - 🧠 ANSWER
✔✔IVIG administration - blood levels of Igs rise to a peak and then
decrease over time until the next infusion
, An Ig blood level taken just before a subsequent infusion is called the
trough level.
SCIG administration - the peaks and troughs are less dramatic, and there is
a more consistent, steady level over time
How is HyQvia administered? - 🧠 ANSWER ✔✔The HY component is
administered first at 1-2 mL per minute/infusion site or as tolerated.
Immediately following, within approximately 10 minutes, the Ig component
is infused through the same high flow subcutaneous needle set
What are other names for HyQvia? - 🧠 ANSWER ✔✔IgHy
fSCIG
What is the advantage of Hyaluronidase in HyQvia? - 🧠 ANSWER ✔✔it
transiently increases the permeability of
the subcutaneous tissue, allowing up to 600 mL of the Ig to be
administered per infusion site
